# This AI Drug Discovery System Actually Worked in a Human Trial - Date: 2026-03-23 - Category: Agentics Insilico Medicine, the Hong Kong-based AI drug discovery company that went public on the Hong Kong Exchange in December 2025, has launched PandaClaw — an agentic AI system purpose-built for biologists working on therapeutic discovery. ---